XML 53 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
Goodwill (Tables)
12 Months Ended
Dec. 31, 2018
Summary of Changes in the Carrying Amount of Goodwill by Segment

The changes in the carrying amount of goodwill for the years ended December 31, 2018 and 2017 were as follows:

 

    Generics     Specialty     Other     Total     North
America
    Europe     International
Market
    Other     Total  
    (U.S. $ in millions)     (U.S. $ in millions)        

Balance as of January 1, 2017 (1)

    32,863       9,323       2,223       44,409       —         —         —         —         —    

Changes during the year:

                 

Goodwill adjustments (2)

    1,480         (560     920       —         —         —         —         —    

Goodwill disposal (3)

    (7     (690       (697     —         —         —         —         —    

Goodwill impairment (4)

    (16,500       (600     (17,100     —         —         —         —         —    

Goodwill reclassified as assets to held for sale (5)

    —         (275       (275     —         —         —         —         —    

Translation differences

    1,028       106       23       1,157       —         —         —         —         —    
 

 

 

   

 

 

   

 

 

   

 

 

           

Balance as of December 31, 2017 (1)

  $ 18,864     $ 8,464     $ 1,086     $ 28,414     $ —       $ —       $ —       $ —       $ —    

Relative fair value allocation

    (18,864     (8,464     (1,086     (28,414     11,144       9,001       5,404       2,865       28,414  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of January 1, 2018

    —         —         —         —         11,144       9,001       5,404       2,865       28,414  

Changes during the year:

                 

Goodwill impairment (6)

    —         —         —         —         —           (2,834     (193     (3,027

Goodwill disposal (7)

    —         —         —         —         —         (65     (14     —         (79

Goodwill reclassified as assets to held for sale

    —         —         —         —         —         (3     —         (17     (20

Translation differences and Other

    —         —         —         —         (46     (280     (77     32       (371
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of December 31, 2018 (1)

  $ —       $ —       $ —       $ —       $ 11,098     $ 8,653     $ 2,479     $ 2,687     $ 24,917  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(1)

Accumulated goodwill impairment as of December 31, 2018, December 31, 2017 and as of January 1, 2017 was approximately $21.0 billion, $18.0 billion and $900 million, respectively.

(2)

Measurement period adjustments on goodwill acquired in 2016.

(3)

Goodwill on the divestiture of certain Teva generic products, as part of the Actavis Generics acquisition, and the U.S. women’s health business.

(4)

Goodwill impairment is mainly attributable to the U.S. generics reporting unit.

(5)

Represent amounts related to the anticipated divestitures of the non-U.S women’s health products.

(6)

Goodwill impairment mainly attributable to the International Markets, Mexico and Medis.

(7)

Mainly due to the divestment of the women’s health business, the sale of Actavis Brazil and other activities.